000 01256 a2200337 4500
005 20250515221553.0
264 0 _c20110214
008 201102s 0 0 eng d
022 _a1533-4023
024 7 _a10.1097/FJC.0b013e3181e23e2b
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPan, ZhiYuan
245 0 0 _aTargeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cSep 2010
300 _a215-28 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aKATP Channels
_xagonists
650 0 4 _aPotassium Channels, Inwardly Rectifying
_xagonists
650 0 4 _aPropylamines
_xpharmacology
700 1 _aHuang, JingHui
700 1 _aCui, WenYu
700 1 _aLong, ChaoLiang
700 1 _aZhang, YanFang
700 1 _aWang, Hai
773 0 _tJournal of cardiovascular pharmacology
_gvol. 56
_gno. 3
_gp. 215-28
856 4 0 _uhttps://doi.org/10.1097/FJC.0b013e3181e23e2b
_zAvailable from publisher's website
999 _c19768486
_d19768486